Impact of Cardiomyopathy and Arrhythmia Genetic Testing on Clinical Management Decisions

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Genetic testing for cardiomyopathy and arrhythmia (CM/ARRH) provides diagnostic information and informs screening for at-risk relatives. Clinical guidelines recommend genetic testing for these conditions; however, data on how genetic test results influence clinical management recommendations are limited. Here, we determined the frequency of cardiologist-recommended managemen...

Topics

Open a Topic to create a Post that cites this publication.

• Guideline Adherence
• Arrhythmias, Cardiac
• Cardiomyopathies
• Europe
• Health Care Surveys
• Health Services Accessibility
• Practice Patterns, Physicians'
• Surveys and Questionnaires

Identifiers and source

Literature Corpus work

ba152f92-5cb6-5166-b996-06c19565d54c

DOI

10.64898/2026.07.22.26358740